TLR2 and inflammatory bowel disease: This TLR2‐dependent effect is in line with a previous study demonstrating that high activation of TLR2 stimulates IL‐6 secretion.[26] Additionally, these findings also indicate that there is a link between intestinal inflammation and peritoneal inflammation as was also found in another study where peritoneal cytokine levels accurately represented intestinal inflammation in inflammatory bowel disease patients.[27] This implies that orally administered pectins have inhibitory effects on TLR2 in the gastrointestinal tract and thereby prevent the development of peritoneal inflammation.